Acquisitions (Tables)

The following table reflects the consideration transferred and the respective reporting segment for each of the acquisitions:

Name of Acquisition	Date Acquired	Segment	Consideration		Cash Consideration
InVivo Biotech Svs GmbH.	January 2, 2017	BSI	$	9.1	$	9.1
SCIILs GmbH	January 2, 2017	BSI		3.1		3.1
Hysitron, Incorporated	January 23, 2017	BSI		28.8		27.2
Luxendo GmbH	May 5, 2017	BSI		21.9		18.8
XGLab S.r.l.	August 1, 2017	BSI		5.5		5.5
the pTD/ePaTOX II business of Analytik Jena AG	August 2, 2017	BSI		0.4		0.4
MERLIN Diagnostika GmbH	September 20, 2017	BSI		2.5		2.2

			$	71.3	$	66.3

The components and fair value allocation of the consideration transferred in connection with the acquisition were as follows (in millions):

Consideration Transferred:
Cash paid	$	20.1
Cash acquired		(1.3	)
Contingent consideration		3.1

Total consideration transferred	$	21.9


Allocation of Consideration Transferred:
Inventories		1.1
Other current and non-current assets		0.4
Property, plant and equipment		0.3
Intangible assets:
Existing technology		10.9
Trade name		0.8
Goodwill		11.2
Deferred taxes, net		(2.4	)
Liabilities assumed		(0.4	)

Total consideration transferred	$	21.9

The components and fair value allocation of the consideration transferred in connection with the acquisition of Hysitron were as follows (in millions):

Consideration Transferred:
Cash paid	$	27.9
Cash acquired		(0.7	)
Contingent consideration		1.6

Total consideration transferred	$	28.8


Allocation of Consideration Transferred:
Accounts receivable, net	$	3.0
Inventories		3.8
Other current assets		0.2
Property, plant and equipment		0.6
Intangible assets:
Customer relationships		5.8
Existing technology		4.7
Trade name		1.2
Other		0.6
Goodwill		16.6
Deferred taxes, net		(4.1	)
Capital lease		(0.2	)
Liabilities assumed		(3.4	)

Total consideration transferred	$	28.8

The following table reflects the consideration transferred and the respective reporting segment for each of the acquisitions:

Name of Acquisition	Segment	Consideration		Cash Consideration
Yingsheng Technology Pty Ltd	BSI	$	1.7	$	1.2
Renishaw Diagnostics Ltd.	BSI		3.6		1.2
Oxford Instruments Superconducting Wire LLC	BEST		15.9		15.9
Preclinical Imaging Business of OncoVision	BSI		7.4		6.0
Active Spectrum Inc.	BSI		2.8		—

		$	31.4	$	24.3

The components and fair value allocation of the consideration transferred in connection with these acquisitions were as follows (in millions):

Consideration Transferred:
Cash paid	$	25.9
Cash acquired		(1.6	)
Shares issued		2.0
Contingent consideration		5.1

Total consideration transferred	$	31.4


Allocation of Consideration Transferred:
Accounts receivable	$	6.9
Inventories		19.1
Other current assets		0.1
Property, plant and equipment		7.5
Intangible assets:
Customer relationships		2.0
Existing technology		14.6
Trade name		0.6
Goodwill		1.0
Bargain purchase gain		(9.2	)
Deferred taxes, net		(1.0	)
Liabilities assumed		(10.2	)

Total consideration transferred	$	31.4

The components and fair value allocation of the consideration transferred in connection with the acquisition of Jordan Valley were as follows (in millions):

Consideration Transferred:
Cash paid	$	35.4
Cash acquired		(6.8	)
Contingent consideration		4.1

Total consideration transferred	$	32.7


Allocation of Consideration Transferred:
Accounts receivable	$	3.8
Inventories		10.5
Other current assets		2.2
Property, plant and equipment		1.6
Intangible assets:
Customer relationships		6.8
Existing technology		6.0
Trade name		1.5
Goodwill		6.3
Liabilities assumed		(6.0	)

Total consideration transferred	$	32.7